EBAC-Accredited Workshop Set for Sept. 3
UPPSALA, Sweden and WILMINGTON, Mass., Aug. 31 /PRNewswire/ -- Nico Pijls, M.D., Ph.D., and Bernard de Bruyne, M.D., Ph.D., will present the benefits of measuring coronary pressure, or Fractional Flow Reserve (FFR), in improving the outcomes of multivessel PCI in a workshop at the European Society of Cardiology (ESC) Congress 2007 in Vienna. The EBAC-accredited workshop, which is sponsored by Radi Medical Systems, will take place at 12:45 p.m. CEST on Monday, Sept. 3, in the Copenhagen Room in Zone 1 of the Messe Wien Conference Center.
Dr. Pijls, of the department of cardiology at Catharina Hospital in Eindhoven, the Netherlands, will cover "Assessment Of Ischaemia In The Cathlab: The Best And Easiest Way To Go." Dr. de Bruyne, with the Cardiovascular Center Aalst in Aalst, Belgium, will explore the "Diagnosis And Treatment Of Multivessel Disease: All In One." Both physicians were investigators in the DEFER study, which evaluated the appropriateness of stenting a coronary stenosis (abnormal narrowing) that appears to be angiographically significant but is not restricting blood flow enough to cause symptoms. Five-year results were published in the May 29 issue of the Journal of the American College of Cardiology.
FFR expresses maximum achievable blood flow in a coronary artery with abnormal stenosis as a fraction of normal maximum blood flow in the absence of a stenosis. It is calculated using an interventional guidewire with a specially designed sensor built into it. Using the well established value of 0.75, FFR is 100% specific in identifying which lesions are actually causing flow restriction and can be treated. FFR also documents the exact percentage of the reduction in flow associated with each lesion.
About Radi Medical Systems AB
Radi Medical Systems AB (Radi) develops, manufactures and sells medical devices designed to improve patient care. The company's pioneering work in the field of interventional cardiology has resulted in market-leading intravascular sensors and hemostasis management and radiology devices. Radi works closely with medical practitioners to develop solutions that address clinical needs, as well as provide clinical education support. Founded in 1988, Radi employs more than 350 people globally and has representation in more than 40 countries. The company is based in Uppsala, Sweden, and maintains a U.S. headquarters in Wilmington, Mass. For more information, visit http://www.radi.se.
David Schull or Benjamin Carmichael
Russo Partners LLC
Radi Medical Systems Inc.
+1 877-337-7234 x812
|SOURCE Radi Medical Systems AB|
Copyright©2007 PR Newswire.
All rights reserved